Bay City Capital GF Xinde International Life Sciences Usd Fund, L.P.
Bay City Capital GF Xinde Investment · adviser of record: Bay City Capital GF Xinde Investment Management CO · 2015 vintage
Bay City Capital GF Xinde International Life Sciences Usd Fund, L.P. is a 2015 venture fund managed by Bay City Capital GF Xinde Investment, with $200mm raised (Form D, amount sold). It reported $30.3mm in gross assets at year-end 2025, 0.15x its size, against a peak of $98.5mm in 2018.
- Latest value held
- $30.3mm year-end 2025
- Peak
- $98.5mm year-end 2018
- Fund size
- $200mm Form D, amount sold
- Held vs. size
- 0.15x peak 0.49x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $30.3mm | 0.15x | +71% over 2 yrs |
| 2023 | $17.7mm | 0.09x | -41% |
| 2022 | $30.1mm | 0.15x | -52% |
| 2021 | $62.2mm | 0.31x | +16% |
| 2020 | $53.8mm | 0.27x | -26% |
| 2019 | $72.6mm | 0.36x | -26% |
| 2018 | $98.5mm | 0.49x | +4% |
| 2017 | $94.3mm | 0.47x | -2% |
| 2016 | $96.4mm | 0.48x | – |
| 2015 | $0k | 0.00x | – |
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-1055263489. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.